BioNTech SE (BNTX) Revenue (2018 - 2026)
BioNTech SE (BNTX) recorded Revenue of $122.75 million in Q2 2026, down 58.4% from $295.22 million a year earlier and down 11.2% from the prior quarter.
Powered by 
Analysis
BioNTech SE (BNTX) Revenue (2018 - 2026) Analysis & Trends
On a TTM basis, BioNTech SE's Revenue came in at $3.09 billion as of Jun 30, 2026, down 1.1% year-over-year; for FY2025, it came in at $3.34 billion, up 13.6% from FY2024.
- Annual Revenue has a five-year compound annual growth rate of 43.4% (FY2020 to FY2025).
- Across earlier years, Revenue came in at $2.94 billion in FY2024 (-28.5%), $4.11 billion in FY2023 (-76.7%), $17.66 billion in FY2022 (-18.6%) and $21.71 billion in FY2021.
- The Q2 2026 figure is the lowest quarterly Revenue since Q3 2020.
- On a year-over-year basis, Revenue has declined for three consecutive quarters, with growth averaging 6.7% over the last eight quarters.
- Peak year-over-year performance for Revenue in the last five years was growth of 189.6% in Q1 2022, against a decline of 94.6% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $138.27 million (Q1 2026), $1.06 billion (Q4 2025) and $1.78 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | BioNTech SE | 25.06 Bn | -34.31 Bn | 10.00 Mn | 122.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 122.75 Mn |
| Mar 31, 2026 | 138.27 Mn |
| Dec 31, 2025 | 1.06 Bn |
| Sep 30, 2025 | 1.78 Bn |
| Jun 30, 2025 | 295.22 Mn |
| Mar 31, 2025 | 192.28 Mn |
| Dec 31, 2024 | 1.27 Bn |
| Sep 30, 2024 | 1.37 Bn |
| Jun 30, 2024 | 138.60 Mn |
| Mar 31, 2024 | 203.80 Mn |
| Dec 31, 2023 | 1.59 Bn |
| Sep 30, 2023 | 974.62 Mn |
| Jun 30, 2023 | 182.61 Mn |
| Mar 31, 2023 | 1.37 Bn |
| Dec 31, 2022 | 4.36 Bn |
| Sep 30, 2022 | 3.49 Bn |
| Jun 30, 2022 | 3.41 Bn |
| Mar 31, 2022 | 7.15 Bn |
| Dec 31, 2021 | 6.33 Bn |
| Sep 30, 2021 | 7.18 Bn |
API Access
BioNTech SE Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=BNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "BNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=BNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();